July, 2025
For Q1 2025, the median transaction value in healthcare was $168 million. For Q1 2025, strategic buyers accounted for 86% of transactions.
Select recent notable publicly announced M&A transactions:
–Roper Technologies closed its acquisition of CentralReach for $1.9 billion in March 2025.
–Advanced Instruments announced its acquisition of Nova Biomedical Corporation for $2.2 billion in March 2025.
–Paratek Pharmaceuticals closed its acquisition of OptiNose for $374 million in March 2025.
–Novartis closed its acquisition of Anthos Therapeutics for $3.1 billion in February 2025.
–Lantheus Medical Imaging closed its acquisition of Evergreen Theragnostics for $1 billion in January 2025.
Securities offered through Peakstone Securities, LLC member FINRA/SIPC. All investments involve market risks, including the loss of principal. Past performance does not guarantee future results. Information on this website is not intended to be a recommendation or specific investment advice. Securities or companies mentioned are for illustrative purposes only and are not a recommendation to buy or sell. Investment decisions should be made based on an individual’s objectives and risk tolerance. Information on this website is intended for US residents only and does not constitute an offer to buy or sell securities in any jurisdiction to whom it is not lawful to make such an offer. Peakstone Securities, LLC is registered as a broker-dealer in the following states: Click here to see licensed states. The information provided does not constitute an offer to buy or sell in any jurisdiction to whom it is not lawful to make such an offer.
Download Report
